Ask AI
ProCE Banner Events

Share

Beyond Basics in Atopic Dermatitis Care: Are You Behind the Curve With Advanced Biologics for Moderate to Severe Disease?

Join us to hear expert guidance on evaluating patient eligibility and implementing treatment plans using IL-4/IL-13–targeting or IL-13–targeting therapies for moderate to severe atopic dermatitis. In addition, hear our discussion on the recent safety and efficacy data for available biologic therapies and clinical case challenges to competently navigate treatment decisions for patients with moderate to severe atopic dermatitis.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Who Should Attend

This education is intended for dermatologists and nurse practitioners/physician associates who manage patients with moderate to severe atopic dermatitis.

Time and location

Tuesday, June 24, 2025

7:00 PM - 8:00 PM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group NY
Franklin Square, New York 11010

United States of America

Location

Venue Name

CCO Simulcast | Host Group NY

Address

CCO Simulcast | Host Group NY
Franklin Square, New York 11010

United States of America

CME/CE Info

Goal Statement
The goal of this educational activity is to improve learners’ knowledge and competence in managing advanced therapy for patients with moderate to severe atopic dermatitis. 

Target Audience
This education is intended for dermatologists and nurse practitioners/physician associates who manage patients with moderate to severe atopic dermatitis.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Evaluate patient eligibility for treatment with available and emerging biologic therapies targeting IL-4/IL-13 and IL-13 for moderate to severe AD
  • Appraise the medical need, clinical rationale, and clinical evidence on available and emerging biologic therapies targeting IL-4/IL-13 and IL-13 for patients with moderate to severe AD
  • Integrate recommended disease assessment measures into treatment advancement approaches for patients with moderate to severe AD

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and the National Eczema Association. Clinical Care Options, LLC (CCO ) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association.

CCO 2022

Supporter

This activity is supported by an educational grant from Lilly.

Lilly

Partner

Practicing Clinicians Exchange, LLC

Practicing Clinicians Exchange, LLC

National Eczema Association

National Eczema Association

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.